华熙生物科技股份有限公司

Bloomage Biotechnology Corp. Ltd. Bloomage Biotechnology Corp. Ltd.

Country: CN DMF+CEP MEDIUM

🇨🇳 CDE

0

0 products shown

🇺🇸 DMF

13

13 products shown

🇪🇺 CEP

11

11 products shown

Total

24

registrations

🇺🇸 DMF 注册 (13)

Product CAS DMF Number Date
Ectoine (ectoine-200) 96702-03-3 - 2022-12-30
Sodium Hyaluronate (ha-e 2.0) 9067-32-7 - 2013-07-31
Sodium Hyaluronate (ha-e 3.0) 9067-32-7 - 2012-08-20
Sodium Hyaluronate (ha-ep 1.2) 9067-32-7 - 2021-05-11
Sodium Hyaluronate (ha-ep 1.8) 9067-32-7 - 2010-12-20
Sodium Hyaluronate (ha-ep 2.4) 9067-32-7 - 2021-04-29
Sodium Hyaluronate (ha-ep 3.0) 9067-32-7 - 2010-12-20
Sodium Hyaluronate (ha-ep-n 2.5) 9067-32-7 - 2021-06-06
Sodium Hyaluronate (ha-ep-n1.3) 9067-32-7 - 2023-03-14
Sodium Hyaluronate (ha-ep-n1.8) 9067-32-7 - 2023-05-08
Sodium Hyaluronate (ha-ep-s3.0)

透明质酸钠

 9067-32-7 - 2025-07-30
Sodium Hyaluronate (ha-p-0.5) 9067-32-7 - 2012-05-07
Sodium Hyaluronate (non-sterile Bulk Form) 9067-32-7 - 2006-03-16

🇪🇺 CEP 注册 (11)

Product CAS CEP Number Date
Sodium Hyaluronate, Ha-e2.0 (intrinsic Viscosity 1.2-2.8 M3/kg), From Fermentation, For Parenteral Administration Other Than Intra-articular Administration And Intra-ocular Use 9067-32-7 CEP 2015-200 - Rev 01 -
Sodium Hyaluronate, Ha-e3.0 (intrinsic Viscosity 2.7-3.6 M3/kg), From Fermentation, For Parenteral Administration Other Than Intra-articular Administration And Intra-ocular Use 9067-32-7 R1-CEP 2015-201 - Rev 00 -
Sodium Hyaluronate, Ha-ep 1.8 (intrinsic Viscosity: 1.6-2.2 M3/kg); From Fermentation; For Parenteral Administration Including Intra-articular Administration And Intra-ocular Use 9067-32-7 CEP 2010-289 - Rev 04 -
Sodium Hyaluronate, Ha-ep 3.0 (intrinsic Viscosity: 2.7-3.6 M3/kg); From Fermentation; For Parenteral Administration Including Intra-articular Administration And Intra-ocular Use 9067-32-7 CEP 2010-290 - Rev 04 -
Sodium Hyaluronate, Intrinsic Viscosity 0.6 M3/kg And 0.8 M3/kg, By Fermentation, For Parenteral Administration Including Intra-articular Administration And For Intra-ocular Use 9067-32-7 R0-CEP 2021-446 - Rev 01 -
Sodium Hyaluronate, Intrinsic Viscosity 1.25 M3/kg, By Fermentation, For Parenteral Administration Including Intra-articular Administration And For Intra-ocular Use 9067-32-7 R0-CEP 2021-258 - Rev 02 -
Sodium Hyaluronate, Intrinsic Viscosity 1.4 M3/kg And 1.0 M3/kg, By Fermentation, For Parenteral Administration Including Intra-articular Administration And For Intra-ocular Use 9067-32-7 R1-CEP 2016-172 - Rev 00 -
Sodium Hyaluronate, Intrinsic Viscosity 1.8 M3/kg, By Fermentation, For Parenteral Administration Including Intra-articular Administration And For Intra-ocular Use 9067-32-7 CEP 2021-220 - Rev 02 -
Sodium Hyaluronate, Intrinsic Viscosity 2.4 M3/kg, By Fermentation, For Parenteral Administration Including Intra-articular Administration And For Intra-ocular Use 9067-32-7 CEP 2018-107 - Rev 04 -
Sodium Hyaluronate, Intrinsic Viscosity 2.5 M3/kg, By Fermentation, For Parenteral Administration Including Intra-articular Administration And For Intra-ocular Use 9067-32-7 CEP 2017-195 - Rev 01 -
Sodium Hyaluronate, Intrinsic Viscosity 3.8 M3/kg, By Fermentation, For Parenteral Administration Including Intra-articular Administration And For Intra-ocular Use 9067-32-7 R0-CEP 2022-129 - Rev 01 -

Source: cde_raw+map_250k | Updated: 2026-04-09 07:23:01